Intra Nasal In situ Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer

scientific article published on 29 December 2017

Intra Nasal In situ Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2174/1874104501711010222
P932PMC publication ID5769127
P698PubMed publication ID29399211

P2093author name stringAsha Paul
K M Fathima
Sreeja C Nair
P2860cites workFormulation, in-vitro characterization and clinical evaluation of curcumin in-situ gel for treatment of periodontitis.Q51843044
Preparation and evaluation of novel in situ gels containing acyclovir for the treatment of oral herpes simplex virus infections.Q51846194
Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease.Q52078340
An in-vitro investigation of mucosa-adhesive materials for use in controlled drug deliveryQ53911721
Lamotrigine for the treatment of bipolar disorder: a clinical case series.Q53930598
Chitosan microspheres as a delivery system for nasal insufflationQ57646930
A comparison of intranasal betamethasone valerate and sodium cromoglycate in seasonal allergic rhinitisQ67512738
Nasal administration of desmopressin by spray and dropsQ69912201
Rheological evaluation of poloxamer as an in situ gel for ophthalmic useQ77486043
Rheological evaluation of Gelrite in situ gels for ophthalmic useQ77486047
Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsyQ77745896
Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacyQ80003220
PecSys: in situ gelling system for optimised nasal drug deliveryQ83766460
Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of PediatricsQ30977510
Bioadhesive-based dosage forms: the next generationQ33947116
Transport of drugs from the nasal cavity to the central nervous systemQ33983028
Modeling and comparison of dissolution profilesQ34215811
Development and Characterization of Mucoadhesive In Situ Nasal Gel of Midazolam Prepared with Ficus carica MucilageQ34280244
In vitro evaluation of proniosomes as a drug carrier for flurbiprofenQ34293795
Permeability issues in nasal drug delivery.Q35053139
Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodinQ35577207
A novel in situ gel base of deacetylase gellan gum for sustained ophthalmic drug delivery of ketotifen: in vitro and in vivo evaluationQ35914774
Mechanisms of action of antiepileptic drugs.Q36002922
The estrogenicity of methylparaben and ethylparaben at doses close to the acceptable daily intake in immature Sprague-Dawley rats.Q36845847
Design and development of hydrogel beads for targeted drug delivery to the colonQ37360715
Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptanQ37360797
The nasal mucociliary clearance: relevance to nasal drug deliveryQ37400782
In situ forming polymeric drug delivery systemsQ37758267
Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochlorideQ38563332
Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.Q39316064
Preparation and evaluation of soft gellan gum gel containing paracetamolQ39643615
Formulation and Evaluation of in situ Gels Containing Clotrimazole for Oral CandidiasisQ40407102
Development and evaluation of in situ nasal gel formulations of loratadineQ41345551
Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochlorideQ41675005
Thermally triggered mucoadhesive in situ gel of loratadine: β-cyclodextrin complex for nasal delivery.Q41988042
Thermoreversible nasal in situ gel of venlafaxine hydrochloride: formulation, characterization, and pharmacodynamic evaluationQ41988093
Development and characterization of in situ oral gel of spiramycinQ42733312
Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate.Q42753080
Formulation and in Vitro, ex Vivo and in Vivo Evaluation of Elastic Liposomes for Transdermal Delivery of Ketorolac TromethamineQ42830830
Development and evaluation of in situ gel of pregabalinQ43136193
Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in ratsQ43210325
Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterizationQ43610260
Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.Q44688372
Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tabletsQ44752324
Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamineQ46266542
Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport propertiesQ46325300
In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoateQ46342683
Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?Q48369715
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectlamotrigineQ410346
P304page(s)222-244
P577publication date2017-12-29
P1433published inThe open medicinal chemistry journalQ27722365
P1476titleIntra Nasal In situ Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer
P478volume11